PDF《中国流感疫苗预防接种技术指南》

6 months and above who are willing to be vaccinated and do not have contraindications. No preferential recommendation is made for one influenza vaccine product over another for persons for whom more than one licensed, recommended, and appropriate product is available. To decrease the risk of severe infections and complications due to influenza virus infection among high risk groups, the recommendations prioritize seasonal influenza vaccination for children aged 6-59 months, adults ≥60 years of age, persons with specific chronic diseases, healthcare workers, the family members and caregivers of infants /=18 years[J]. BMC Infect Dis, 2013, 13: 343. [205] Langley JM, Carmona MA, Chatterjee A, et al. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children[J]. J Infect Dis, 2013, 208(4): 544-553. [206] 胡昱, 李倩, 陈雅萍, 等.

18 岁以上人群接种四价流感病毒灭活疫苗免疫原性和 安全性的 Meta 分析[J]. 国际流行病学传染病学杂志, 2017, 44(1): 47-52. [207] Nichol KL. Heterogeneity of influenza case definitions and implications for interpreting and comparing study results[J]. Vaccine, 2006, 24(44-46): 6726-6728. [208] Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness[J]. Vaccine, 2013, 31(17): 2165-2168. [209] Sullivan SG, Feng S, Cowling BJ. Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review[J]. Expert Rev Vaccines, 2014, 13(12): 1571-1591. [210] Zhao YW, Feng ZJ. [The meta analysis on the safety and immunogenicity of domestic and imported split influenza virus vaccines][J]. Zhongguo Yi Miao He Mian Yi, 2009, 15(1): 19-26. [211] Ren J, Shen J, Chen W, et al. [Meta analysis on the immunogenicity of domestic influenza virus vaccines][J]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2013, 29(9): 981-985. [212] Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2012, 12(1): 36-44. [213] Demicheli V, Jefferson T, Ferroni E, et al. Vaccines for preventing influenza in healthy adults[J]. Cochrane Database Syst Rev, 2018, 2: CD001269. [214] Belongia EA, Simpson MD, King JP, et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies[J]. Lancet Infect Dis, 2016, 16(8): 942-951. [215] Xing Y, Liu M. [Meta analysis on the effectiveness of inactivated influenza vaccine][J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2009, 30(4): 368-370. [216] Ma C, Pan Y, Zhang L, et al. Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season[J]. Hum Vaccin Immunother, 2017, 13(10): 2379-2384. [217] Wu S, Pan Y, Zhang X, et al. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient........